Kennedy has suggested he would ban fluoride in drinking water after being appointed to an unspecified health post in former ...
Pre-earnings options volume in Corvus Pharmaceuticals (CRVS) is normal with calls leading puts 8:5. Implied volatility suggests the market is ...
Formosa Pharmaceuticals has announced the completion and top-line results from CPN-303, a phase 3 clinical study of APP13007 ...
Zacks.com on MSN2d
Royalty Pharma (RPRX) Q3 Earnings and Revenues Surpass EstimatesRoyalty Pharma (RPRX) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.79 per share a year ago. These ...
Shares of Piramal Pharma (PPL) hit a new peak of Rs 307.85, soaring 13 per cent on the BSE in Wednesday’s intra-day trade ...
Shares of Gland Pharma Ltd. were trading with gains of up to 10% on Tuesday, November 5. The stock has corrected 24% over ...
Pharmaceutical water systems in transformation mode with advanced processes & shift towards analytics: Nandita Vijayasimha, Bengaluru Thursday, November 7, 2024, 08:00 Hrs [IST] I ...
Stock Market Today: Multibagger stock, Sudarshan Pharma Industries Ltd has declares 1:10 stock split after 400% rally YTD ...
Topline results are anticipated in Q4 2025 and, assuming positive data, Averitas Pharma aims to submit a supplemental new drug application (sNDA) in 2026. [1] Rosenberger DC, Pogatzki-Zahn EM.
Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...
Gland Pharma shares rallied nearly 12% to Rs 1,799 in Monday's trade on BSE after the company reported a 15.7% year-on-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback